De novo mutations in KCNA2 are associated with epileptic encephalopathy, with about half of the patients with KCNA2 mutations showing symptoms of ataxia and atrophy of the cerebellum (Table 1) [32]. Here, KCNA2 is linked to Epileptic encephalopathy.